Why the study?
Does instillation of triamcinolone hexacetonide via prolonged pericardial drainage improve recovery and prevent recurrence in patients with intractable uremic pericarditis?
Does instillation of triamcinolone hexacetonide via prolonged pericardial drainage improve recovery and prevent recurrence in patients with intractable uremic pericarditis?
Intrapericardial instillation of triamcinolone hexacetonide with prolonged drainage may be an effective, non-surgical alternative for managing intractable uremic pericarditis.
Answers are grounded in this paper and cite their sources.
May support intrapericardial triamcinolone for intractable uremic pericarditis; hypothesis-generating and requires prospective trials before practice change.
Of 74 patients undergoing long-term hemodialysis who were observed during a 21-month period, seven developed uremic pericarditis. Five of these patients developed intractable pericarditis, unresponsive to intensive dialysis and pericardiocentesis, and were treated with prolonged pericardial drainage (16 to 60 hours) by an indwelling polyethylene catheter and instillation of triamcinolone hexacetonide. Evidence of intractability was based on either the recurrence of cardiac tamponade after pericardiocentesis (two patients) or progression in the size of the pericardial effusion despite four weeks of intensive dialysis (three patients). These five patients recovered and subsequently were observed from 1 to 15 months with no evidence of recurrent pericarditis. This procedure may be an effective alternative to the surgical management of intractable uremic pericarditis, particularly in the patient at high risk for anesthesia and major surgery.
No takes yet. Share an insight, caveat, or question.
Thomas J. Fuller (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: